CGA polymorphism of androgen receptor: a potential role in modulating the PDE5 inhibitor (tadalafil)
The aim of the project is to evaluate the levels of testosterone after tadalafil therapy (5 mg / day) in eugonadic subjects with erectile dysfunction. Evaluations will be made at baseline and after 2 months. In addition, it will be evaluated even if the androgen receptor CAG polymorphism affects the response to tadalafil.
This job comes from a partnership with Science Magazine and